iShares JP Morgan EM Corporate Bond ETF (CEMB)

46.01 +0.26  +0.57% BATS Apr 7, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 45.68
Discount or Premium to NAV 0.72%
Turnover Ratio 21.00%
1 Year Fund Level Flows 78.67M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -11.29% -12.18% -15.46% 15
3M -10.58% -10.63% -15.30% 13
6M -8.02% -8.64% -13.17% 13
YTD -10.15% -10.21% -15.16% 13
1Y -3.64% -3.57% -9.81% 11
3Y 1.13% 1.04% -1.49% 8
5Y 2.83% 2.69% 1.13% 7
10Y -- -- 3.36% --
15Y -- -- 5.25% --
20Y -- -- 7.59% --
As of April 7, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.78% 1.15% 0.37%
Stock 0.00% 0.00% 0.00%
Bond 97.06% 97.06% 0.00%
Convertible 2.16% 2.16% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 6, 2020

Region Exposure

Americas 24.18%
North America 0.14%
Latin America 24.04%
Greater Europe 36.55%
United Kingdom 0.61%
Europe Developed 1.67%
Europe Emerging 11.17%
Africa/Middle East 23.10%
Greater Asia 38.40%
Japan 0.00%
Australasia 0.00%
Asia Developed 16.26%
Asia Emerging 22.14%
Market Classification
% Developed Markets 29.30%
% Emerging Markets 70.70%
As of April 6, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

CEMB Bond Exposure

Government 7.48%
Corporate 91.38%
Securitized 0.00%
Municipal 0.00%
Cash 1.14%
Derivative 0.00%
As of April 6, 2020

CEMB Bond Credit Quality Exposure

AAA 0.54%
AA 2.00%
A 20.12%
BBB 39.13%
BB 19.19%
B 12.36%
Below B 4.08%
Not Rated 2.57%
As of Dec. 31, 2019

CEMB Bond Maturity Exposure

1 to 7 Days 0.00%
8 to 30 Days 0.00%
31 to 90 Days 0.00%
91 to 182 Days 0.00%
183 to 364 Days 0.00%
1 to 3 Years 14.04%
3 to 5 Years 29.41%
5 to 7 Years 16.29%
7 to 10 Years 20.31%
10 to 15 Years 2.50%
15 to 20 Years 4.41%
20 to 30 Years 12.51%
Over 30 Years 0.54%
As of April 6, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Teva Pharmaceutical Finance Netherlands III B.V. 3.15% 0.71% -- --
-- Saudi Arabian Oil Company 4.25% 0.67% -- --
-- Saudi Arabian Oil Company 3.5% 0.66% -- --
-- Saudi Arabian Oil Company 4.38% 0.54% -- --
-- Teva Pharmaceutical Finance Netherlands III B.V. 2.8% 0.53% -- --
-- Altice Financing S.A. 7.5% 0.52% -- --
-- Sands China Ltd 5.13% 0.51% -- --
-- Teva Pharmaceutical Finance Netherlands III B.V. 6% 0.45% -- --
-- Ecopetrol S.A. 5.88% 0.43% -- --
-- VTB Capital S.A. 6.95% 0.41% -- --
As of April 6, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the investment results of the J.P. Morgan CEMBI Broad Diversified Core Index composed of U.S. dollar-denominated, emerging market corporate bonds. The fund generally will invest at least 90% of its assets in the component securities of the underlying index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index tracks the performance of the U.S. dollar-denominated emerging market corporate bond market.
General
Security Type Exchange-Traded Fund
Equity Style --
Fixed Income Style Low Quality/Moderate Sensitivity
Broad Asset Class Taxable Bond
Broad Category Fixed Income
Category Name Emerging Markets Bond
Prospectus Objective Income
Fund Owner Firm Name iShares
Benchmark Index
JPM CEMBI Broad Diversified Core TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
James Mauro 7.96 yrs
Scott Radell 7.96 yrs

Net Fund Flows

1M -43.80M
3M -7.43M
6M 20.73M
YTD -7.43M
1Y 78.67M
3Y 104.02M
5Y 144.23M
10Y --
As of March 31, 2020

Risk Info

Beta (5Y) 0.8454
Max Drawdown (All) 20.84%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.1585
30-Day Rolling Volatility 31.59%
Daily Value at Risk (VaR) 1% (All) 1.46%
Monthly Value at Risk (VaR) 1% (All) 6.81%

Fundamentals

Dividend Yield TTM (4-7-20) 4.73%
30-Day SEC Yield (4-6-20) 5.65%
7-Day SEC Yield --
Current Yield 5.21%
Yield to Maturity 4.47%
Effective Duration 4.881
Average Coupon 5.02%
Average Credit Score 13.00 (BB)
Average Price --
Number of Holdings 636
As of April 6, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 4/17/2012
Termination Date
Last Annual Report Date 10/31/2019
Last Prospectus Date 2/28/2020
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.